David M.  Stack net worth and biography

David Stack Biography and Net Worth

Director of Amarin
David Stack joined Amarin as a Non-Executive Director in December 2012. Mr. Stack is currently the President and Chief Executive Officer of Pacira Pharmaceuticals, Inc. Mr. Stack has been a managing director of MPM Capital since 2005 and a managing partner of Stack Pharmaceuticals, Inc. since 1998. From 2001 to 2004, he was President and Chief Executive Officer of The Medicines Company. Previously, Mr. Stack was President and General Manager at Innovex, Inc. He was Vice President, Business Development/Marketing at Immunomedics from 1993 until 1995. Prior to that, he was with Roche Laboratories from 1981 until 1993, in various positions including therapeutic world leader in infectious disease and director, business development and planning, infectious disease, oncology, and virology. He currently serves as a member of the board of directors of Pacira Pharmaceuticals, Inc., PepTx, Inc. and Medivo, Inc. He was a member of the boards of directors of Molecular Insight Pharmaceuticals, Inc. from 2006 to 2010 and BioClinica, Inc. from 1999 to 2010. Mr. Stack holds a B.S. in pharmacy from Albany College of Pharmacy and a B.S. in Biology from Siena College. We believe Mr. Stack's qualifications to sit on our board of directors include his extensive experience with pharmaceutical companies, his financial expertise and his years of experience providing strategic and financial advisory services to pharmaceutical and biotechnology organizations.

What is David M. Stack's net worth?

The estimated net worth of David M. Stack is at least $140,014.16 as of June 6th, 2023. Mr. Stack owns 159,107 shares of Amarin stock worth more than $140,014 as of March 28th. This net worth estimate does not reflect any other investments that Mr. Stack may own. Learn More about David M. Stack's net worth.

How do I contact David M. Stack?

The corporate mailing address for Mr. Stack and other Amarin executives is 77 Sir John Rogerson`s Quay Block C Grand Canal Docklands, Dublin L2, Dublin 2. Amarin can also be reached via phone at (531) 669-9020 and via email at [email protected]. Learn More on David M. Stack's contact information.

Has David M. Stack been buying or selling shares of Amarin?

David M. Stack has not been actively trading shares of Amarin during the past quarter. Most recently, on Thursday, June 3rd, David M. Stack bought 5,000 shares of Amarin stock. The stock was acquired at an average cost of $4.62 per share, with a total value of $23,100.00. Learn More on David M. Stack's trading history.

Who are Amarin's active insiders?

Amarin's insider roster includes Michael Kalb (CFO), Joseph Kennedy (General Counsel), Steven Ketchum (Insider), David Stack (Director), and Joseph Zakrzewski (Director). Learn More on Amarin's active insiders.

Are insiders buying or selling shares of Amarin?

During the last twelve months, Amarin insiders bought shares 2 times. They purchased a total of 314,426 shares worth more than $327,724.34. During the last twelve months, insiders at the biopharmaceutical company sold shares 1 times. They sold a total of 34,131 shares worth more than $26,963.49. The most recent insider tranaction occured on January, 22nd when CEO Patrick Holt bought 14,426 shares worth more than $15,724.34. Insiders at Amarin own 2.0% of the company. Learn More about insider trades at Amarin.

Information on this page was last updated on 1/22/2024.

David M. Stack Insider Trading History at Amarin

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/3/2021Buy5,000$4.62$23,100.00View SEC Filing Icon  
11/30/2020Buy25,000$4.86$121,500.00View SEC Filing Icon  
7/11/2019Sell51,991$22.28$1,158,359.48View SEC Filing Icon  
5/29/2019Sell33,799$18.45$623,591.55View SEC Filing Icon  
5/17/2019Sell13,174$18.00$237,132.00View SEC Filing Icon  
See Full Table

David M. Stack Buying and Selling Activity at Amarin

This chart shows David M Stack's buying and selling at Amarin by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Amarin Company Overview

Amarin logo
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $0.89
Low: $0.88
High: $0.91

50 Day Range

MA: $1.08
Low: $0.82
High: $1.35

2 Week Range

Now: $0.89
Low: $0.65
High: $1.56

Volume

1,152,657 shs

Average Volume

2,187,589 shs

Market Capitalization

$365.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.01